[HTML][HTML] Advances of medical nanorobots for future cancer treatments

X Kong, P Gao, J Wang, Y Fang, KC Hwang - Journal of Hematology & …, 2023 - Springer
Early detection and diagnosis of many cancers is very challenging. Late stage detection of a
cancer always leads to high mortality rates. It is imperative to develop novel and more …

Theranostic fluorescent probes

A Sharma, P Verwilst, M Li, D Ma, N Singh… - Chemical …, 2024 - ACS Publications
The ability to gain spatiotemporal information, and in some cases achieve spatiotemporal
control, in the context of drug delivery makes theranostic fluorescent probes an attractive …

Nitrogen-centered lactate oxidase nanozyme for tumor lactate modulation and microenvironment remodeling

S Zhao, H Li, R Liu, N Tao, L Deng, Q Xu… - Journal of the …, 2023 - ACS Publications
Designing nanozymes that match natural enzymes have always been an attractive and
challenging goal. In general, researchers mainly focus on the construction of metal centers …

Ultra-stable MOF@ MOF nanoplatform for photodynamic therapy sensitized by relieved hypoxia due to mitochondrial respiration inhibition

J Yu, Q Li, Z Wei, G Fan, F Wan, L Tian - Acta Biomaterialia, 2023 - Elsevier
Metal-organic frameworks (MOFs) with periodically arranged porphyrinic linkers avoiding
the self-quenching issue of porphyrins in photodynamic therapy (PDT) have been widely …

Metal organic frameworks based intelligent nanoadjuvants for boosting tumor immunotherapy through enhanced ICD and lactic acid regulation

H Hu, Z Dai, F Zhang, C Xin, Q An, X Meng, Z Hu… - Chemical Engineering …, 2024 - Elsevier
Immunotherapy has been considered as a potent antitumor modality while its efficacy is
frequently hampered by the insufficient immunogenicity and immunosuppressive tumor …

Site-specific controlled-release nanoparticles for immune reprogramming via dual metabolic inhibition against triple-negative breast cancer

W She, H Li, Z Wang, T Liu, D Zhao, Z Guo, Y Liu… - Journal of Controlled …, 2024 - Elsevier
Metabolic heterogeneity and the tumor immunosuppressive microenvironment (TIME) of
triple-negative breast cancer (TNBC) hinder therapeutic effectiveness. Although emerging …

An engineered Bacterium-based Lactate bioconsumer for regulating immunosuppressive tumor microenvironment to potentiate antitumor immunity

SM Zhang, XK Jin, GF Luo, JL Liang… - ACS Materials …, 2023 - ACS Publications
In this study, a bacterium-based lactate bioconsumer (designated Bac@ RFH) was
elaborately engineered for persistent lactate consumption to potentiate antitumor …

Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy

X Dong, S Xia, S Du, MH Zhu, X Lai, SQ Yao… - ACS Central …, 2023 - ACS Publications
Cancer immunotherapy has become an established therapeutic paradigm in oncologic
therapy, but its therapeutic efficacy remains unsatisfactory in the majority of cancer patients …

Targeting the p53 signaling pathway in cancers: molecular mechanisms and clinical studies

J Shen, Q Wang, Y Mao, W Gao, S Duan - MedComm, 2023 - Wiley Online Library
Tumor suppressor p53 can transcriptionally activate downstream genes in response to
stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis …

Photothermal‐Enhanced Dual Inhibition of Lactate/Kynurenine Metabolism for Promoting Tumor Immunotherapy

Y Xie, M Wang, L Qiao, Y Qian, W Xu, Q Sun… - Small …, 2024 - Wiley Online Library
Traditionally referred to as “metabolic junk”, lactate has now been recognized as essential
“energy currency” and crucial “messenger” that contributes to tumor evolution …